Pharmaceutical Business Review
Return to: PBR Home | Suppliers

Molecular Weight Measurements of an Antibody Using Viscotek SEC-MALS 20

Published 09 October 2014 | By Malvern Panalytical

Therapeutic recombinant antibodies, primarily of the Immunoglobulin G isotype (IgG), represent a growing proportion of biopharmaceuticals. There are an ever increasing number of approved antibody therapies available to treat a variety of modern-day diseases such as cancer, rheumatoid arthritis and diabetes. With many more candidate IgG's in the biopharmaceutical development pipeline the pressure to accurately understand and develop these candidates becomes more and more important.

Available Downloads

Molecular Weight Measurements of an Antibody Using Viscotek SEC-MALS 20